Research progress on the protective effect of hormones and hormone drugs in myocardial ischemia-reperfusion injury

Area of Science:

• Cardiology
• Endocrinology
• Pharmacology

Background:

• Ischemic heart disease (IHD) results from insufficient blood flow to the heart.
• Restoring blood flow is crucial but can paradoxically worsen heart tissue damage (myocardial ischemia/reperfusion injury - MIRI).
• Effective strategies to prevent or manage MIRI are currently limited.

Purpose of the Study:

• To elucidate the mechanisms of hormone pharmaceuticals.
• To emphasize the cardioprotective effects of various endocrine hormones.
• To guide the therapeutic application of hormone drugs for MIRI.

Main Methods:

• Review of existing literature on hormones and hormone medications.
• Analysis of studies examining endocrine hormone analogs' effects on myocardial injury.
• Exploration of the mechanisms of action for different hormone analogs.

Main Results:

• Hormones, including sex hormones and adrenaline medications, show potential cardioprotective properties.
• Some hormone analogs' mechanisms and safety profiles require further investigation.
• Endocrine hormones demonstrate potential in mitigating myocardial ischemia/reperfusion injury.

Conclusions:

• Hormone pharmaceuticals offer promising avenues for managing myocardial ischemia/reperfusion injury.
• Further research is needed to fully understand the mechanisms and ensure the safety of various hormone analogs.
• This study provides a foundation for developing hormone-based therapies to protect the heart during reperfusion.